Jeff Marrazzo, Spark CEO (Credit: Endpoints News)
December 16, 2019 06:29 PM ESTUpdated December 17, 11:28 AM
R&D

FTC to Roche: OK, go ahead and com­plete your $4.3B Spark buy­out — we're con­vinced now this is­n't an­ti­com­pet­i­tive

John Carroll

Editor & Founder

Af­ter putting Roche through mul­ti­ple de­lays dur­ing a 10-month re­view, the FTC has de­ter­mined that Roche isn’t spend­ing $4.3 bil­lion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times